US FDA moved this week to enact multiple provisions of the 21st Century Cures Act, to expand the Humanitarian Device Exemption (HDE) program, streamline clinical-trial requirements and detail which reusable devices are subject to validation data requirements for some reusable devices.
The actions may reflect a pickup in policymaking from the agency now that Scott Gottlieb is in place as a...